Proprietary polymer excipients for drug stabilization
Other Considerations
Raised $16 million in Series Seed financing; Established partnerships with leading pharmaceutical companies; Demonstrated in-vitro and in-vivo safety and efficacy data; Team includes industry veterans from Bigfoot Biomedical and Mode AGC